Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel I Novikov

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of the Rheumatic Diseases|July 24, 2017
Duration of maintenance therapy for ANCA-associated vasculitis: more questions than answersPavel I Novikov, Ilya Smitienko, Sergey V Moiseev
Annals of the Rheumatic Diseases|June 14, 2017
ANCA-associated vasculitis: mission incompleteSergey V Moiseev, Pavel I Novikov, Ilya Smitienko
The Journal of Rheumatology|November 3, 2016
Eotaxin-3 as a Biomarker of Activity in Established Eosinophilic Granulomatosis with PolyangiitisEugenia S Zagvozdkina, Sergey V Moiseev, Pavel I Novikov
Annals of the Rheumatic Diseases|March 4, 2018
The role of temporal artery biopsy in patients with giant-cell arteritis is debatedSergey V Moiseev, Ilya Smitienko, Nikolay Bulanov, et al.
Annals of the Rheumatic Diseases|August 1, 2018
Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimatedNikolai Bulanov, Natalia V Chebotareva, Pavel I Novikov, et al.
Annals of the Rheumatic Diseases|June 21, 2018
Rituximab in ANCA-associated vasculitis: fewer infusions or ultra low-dose maintenance therapy?Sergey V Moiseev, Nikolai M Bulanov, Anastasiia S Zykova, et al.
Annals of the Rheumatic Diseases|February 14, 2019
Changing landscape of immunosuppression in ANCA-associated vasculitisSergey V Moiseev, Ilya Smitienko, Nikolai Bulanov, et al.
Annals of the Rheumatic Diseases|November 26, 2018
Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquinePavel I Novikov, Nikolai M Bulanov, Anastasiia S Zykova, et al.
Annals of the Rheumatic Diseases|May 2, 2019
What rheumatologist should know about Fabry diseaseSergey Moiseev, Ekaterina Karovaikina, Pavel I Novikov, et al.
Rheumatology International|October 27, 2014
Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experiencePavel I Novikov, Sergey V Moiseev, Ekaterina I Kuznetsova, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of the Rheumatic Diseases|July 24, 2017
Duration of maintenance therapy for ANCA-associated vasculitis: more questions than answersPavel I Novikov, Ilya Smitienko, Sergey V Moiseev
Annals of the Rheumatic Diseases|June 14, 2017
ANCA-associated vasculitis: mission incompleteSergey V Moiseev, Pavel I Novikov, Ilya Smitienko
The Journal of Rheumatology|November 3, 2016
Eotaxin-3 as a Biomarker of Activity in Established Eosinophilic Granulomatosis with PolyangiitisEugenia S Zagvozdkina, Sergey V Moiseev, Pavel I Novikov
Annals of the Rheumatic Diseases|March 4, 2018
The role of temporal artery biopsy in patients with giant-cell arteritis is debatedSergey V Moiseev, Ilya Smitienko, Nikolay Bulanov, et al.
Annals of the Rheumatic Diseases|August 1, 2018
Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimatedNikolai Bulanov, Natalia V Chebotareva, Pavel I Novikov, et al.
Annals of the Rheumatic Diseases|June 21, 2018
Rituximab in ANCA-associated vasculitis: fewer infusions or ultra low-dose maintenance therapy?Sergey V Moiseev, Nikolai M Bulanov, Anastasiia S Zykova, et al.
Annals of the Rheumatic Diseases|February 14, 2019
Changing landscape of immunosuppression in ANCA-associated vasculitisSergey V Moiseev, Ilya Smitienko, Nikolai Bulanov, et al.
Annals of the Rheumatic Diseases|November 26, 2018
Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquinePavel I Novikov, Nikolai M Bulanov, Anastasiia S Zykova, et al.
Annals of the Rheumatic Diseases|May 2, 2019
What rheumatologist should know about Fabry diseaseSergey Moiseev, Ekaterina Karovaikina, Pavel I Novikov, et al.
Rheumatology International|October 27, 2014
Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experiencePavel I Novikov, Sergey V Moiseev, Ekaterina I Kuznetsova, et al.
Pageof 2